Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1982 3
1983 1
1984 8
1985 5
1986 4
1987 3
1988 9
1989 3
1990 14
1991 15
1992 16
1993 15
1994 34
1995 30
1996 36
1997 33
1998 27
1999 45
2000 52
2001 83
2002 79
2003 107
2004 119
2005 143
2006 144
2007 197
2008 237
2009 266
2010 312
2011 374
2012 474
2013 512
2014 594
2015 660
2016 661
2017 742
2018 906
2019 1050
2020 1258
2021 1298
2022 1505
2023 1591
2024 353

Text availability

Article attribute

Article type

Publication date

Search Results

12,539 results

Results by year

Filters applied: . Clear all
Page 1
Polarimetric Helmholtz Stereopsis.
Ding Y, Ji Y, Chen Z, Zhou M, Kang SB, Ye J. Ding Y, et al. Among authors: ye j. IEEE Trans Pattern Anal Mach Intell. 2024 Jan 25;PP. doi: 10.1109/TPAMI.2024.3357100. Online ahead of print. IEEE Trans Pattern Anal Mach Intell. 2024. PMID: 38271171
Immune cells and hypertension.
Gan L, Ye D, Feng Y, Pan H, Lu X, Wan J, Ye J. Gan L, et al. Among authors: ye j. Immunol Res. 2024 Feb;72(1):1-13. doi: 10.1007/s12026-023-09414-z. Epub 2023 Dec 4. Immunol Res. 2024. PMID: 38044398 Review.
Context-dependent role of SIRT3 in cancer.
Zhang J, Ye J, Zhu S, Han B, Liu B. Zhang J, et al. Among authors: ye j. Trends Pharmacol Sci. 2024 Feb;45(2):173-190. doi: 10.1016/j.tips.2023.12.005. Epub 2024 Jan 19. Trends Pharmacol Sci. 2024. PMID: 38242748 Review.
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial.
Liu Q, Chen J, Lin Y, Ye J, Shen W, Luo H, Li B, Huang W, Wei S, Song J, Wang Y, Yang H, Lai S, Zhu H, Ai D, Chen Y, Deng J, Hao S, Zhao K. Liu Q, et al. Among authors: ye j. Lancet Gastroenterol Hepatol. 2024 Jan;9(1):45-55. doi: 10.1016/S2468-1253(23)00316-3. Epub 2023 Nov 18. Lancet Gastroenterol Hepatol. 2024. PMID: 37980921 Clinical Trial.
12,539 results
You have reached the last available page of results. Please see the User Guide for more information.